Published in Exp Eye Res on February 01, 1994
Structure-function correlation of the human central retina. PLoS One (2010) 1.12
Scanning laser tomography Z profile signal width as an objective index of macular retinal thickening. Br J Ophthalmol (1998) 1.10
Detecting AMD with multiply scattered light tomography. Int Ophthalmol (2001) 0.91
Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema. Br J Ophthalmol (2003) 0.87
Improved visualisation of choroidal neovascularisation by scanning laser ophthalmoscope using image averaging. Br J Ophthalmol (2005) 0.82
Ocular wavefront aberrations in patients with macular diseases. Retina (2009) 0.80
Noninvasive vascular imaging of ruptured retinal arterial macroaneurysms by Doppler optical coherence tomography. BMC Ophthalmol (2015) 0.79
Comparison of laser ray-tracing and skiascopic ocular wavefront-sensing devices. Eye (Lond) (2007) 0.78
Reproducibility of volumetric macular measurements in diabetic patients with the Heidelberg Retina Tomograph. Doc Ophthalmol (1999) 0.77
Laser imaging of the retina. Br J Ophthalmol (1999) 0.76
Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology (1996) 2.70
Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology (1997) 2.49
Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus) N Engl J Med (1995) 2.47
High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis (1997) 2.14
Visual outcome in acute retinal necrosis. Retina (1993) 1.99
Retina and vitreous pathology after laser-assisted in situ keratomileusis: is there a cause-effect relationship? Ophthalmology (2001) 1.84
Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 1.82
Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol (1998) 1.73
Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis (1998) 1.71
A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol (1984) 1.70
Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Ophthalmology (1996) 1.66
Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology (1987) 1.62
Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol (1987) 1.58
Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina (2001) 1.53
Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest (1995) 1.47
Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.44
Intraocular tolerance of perfluorooctylbromide (perflubron) Retina (1995) 1.44
Exudative retinal detachment following grid laser photocoagulation in a patient with hemiretinal vein occlusion. Eur J Ophthalmol (2001) 1.39
Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis (1999) 1.39
Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol (1995) 1.35
Demonstration of herpes group virus in acute retinal necrosis syndrome. Am J Ophthalmol (1986) 1.33
Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol (2000) 1.33
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol (1998) 1.29
Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol (1997) 1.28
Confocal laser tomographic analysis of the retina in eyes with macular hole formation and other focal macular diseases. Am J Ophthalmol (1989) 1.25
Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report. Ann Intern Med (1996) 1.24
Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol (1987) 1.22
Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol (1997) 1.22
Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle. Br J Ophthalmol (2008) 1.22
Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology (1990) 1.21
Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol (1989) 1.17
Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol (1996) 1.16
Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol (1998) 1.13
Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.11
Ocular examination and diagnosis in patients with the acquired immunodeficiency syndrome. West J Med (1993) 1.10
Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol (1999) 1.08
Wave-front generation of Zernike polynomial modes with a micromachined membrane deformable mirror. Appl Opt (1999) 1.07
Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol (1983) 1.07
Oral fluorescein angiography with the confocal scanning laser ophthalmoscope. Ophthalmology (1999) 1.03
Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group. Am J Ophthalmol (1996) 1.01
Automated scanning laser ophthalmoscope image montages of retinal diseases. Ophthalmology (1999) 1.01
New developments in the treatment of CMV retinitis. Ophthalmology (1996) 1.01
Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J Clin Invest (1995) 1.01
Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis. Am J Ophthalmol (1997) 1.01
A graphical analysis of the interrelationships among waterborne asbestos, digestive system cancer and population density. Environ Health Perspect (1983) 1.01
Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification. Ophthalmology (1992) 1.01
Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral buckling. Ophthalmology (1995) 1.01
Duration of vitrectomy and postoperative cataract in the vitrectomy for macular hole study. Am J Ophthalmol (2001) 1.00
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis (1993) 1.00
Pattern electroretinograms and visual evoked potentials in HIV infection: evidence of asymptomatic retinal and postretinal impairment in the absence of infectious retinopathy. Neurology (1996) 0.99
Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology (2000) 0.99
AIDS-related optic neuropathy: a histological, virological and ultrastructural study. Graefes Arch Clin Exp Ophthalmol (1995) 0.99
Lymphocyte subpopulations in uveitis. Arch Ophthalmol (1986) 0.98
Laser-tissue interaction and artifacts in confocal scanning laser ophthalmoscopy and tomography. Neurosci Biobehav Rev (1993) 0.97
Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humor and vitreous. J Infect Dis (1999) 0.97
Visual dysfunction in HIV-positive patients without infectious retinopathy. AIDS Patient Care STDS (1998) 0.96
Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. J Infect Dis (1993) 0.96
Retinal nerve fiber layer evaluation in human immunodeficiency virus-positive patients. Am J Ophthalmol (2001) 0.96
Rhegmatogenous retinal detachments in HIV-positive patients with ocular syphilis. Ophthalmic Surg Lasers (1996) 0.96
Vitrectomy surgery for full-thickness macular holes. Am J Ophthalmol (1993) 0.95
Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy. Br J Ophthalmol (2003) 0.94
Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug. Invest Ophthalmol Vis Sci (1999) 0.94
Evaluation of microvascularization pattern visibility in human choroidal melanomas: comparison of confocal fluorescein with indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol (1999) 0.94
Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand (1998) 0.93
The 30-degree curved endolaser probe. Ann Ophthalmol (1990) 0.93
Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology (1997) 0.93
The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. HIV Clin Trials (2005) 0.92
New ophthalmic manifestations of presumed rifabutin-related uveitis. Ophthalmic Surg Lasers (1997) 0.92
Retinal blood flow measurements in branch retinal vein occlusion using scanning laser Doppler flowmetry. Am J Ophthalmol (1998) 0.92
Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients. Invest Ophthalmol Vis Sci (1992) 0.92
The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Am J Ophthalmol (1998) 0.92
Clinical and histopathologic study of varicella zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol (1994) 0.92
A simple noncontact wide-angle fundus photography procedure for clinical and research use. Retina (2001) 0.91
Miliary toxoplasmic retinitis in acquired immunodeficiency syndrome. Arch Ophthalmol (1993) 0.91
Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy. Retina (2000) 0.91
CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. AIDS (2000) 0.90
Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol (2006) 0.90
Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. Invest Ophthalmol Vis Sci (2000) 0.90
Retinal detachment. Ophthalmol Clin North Am (2001) 0.89
Adaptive control of a micromachined continuous-membrane deformable mirror for aberration compensation. Appl Opt (1999) 0.89
Scanning laser entoptic perimetry for the screening of macular and peripheral retinal disease. Arch Ophthalmol (2000) 0.89
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis (2001) 0.89
Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates. J Infect Dis (1996) 0.89
A masked prospective evaluation of outcome parameters for cytomegalovirus-related retinal detachment surgery in patients with acquired immune deficiency syndrome. Ophthalmology (1994) 0.88
Macular hole surgery in an eye with an optic pit. Am J Ophthalmol (2001) 0.88
The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy. Curr Eye Res (2000) 0.88
Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center. Invest Ophthalmol Vis Sci (1999) 0.88
Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. Ophthalmology (1997) 0.87
Severe visual loss related to isolated peripapillary retinal and optic nerve head cytomegalovirus infection. Am J Ophthalmol (1989) 0.87
Optic neuropathy preceding acute retinal necrosis in acquired immunodeficiency syndrome. Arch Ophthalmol (1996) 0.87
Cytomegalovirus iritis. Ophthalmic Surg Lasers (1998) 0.87
Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology (1995) 0.86
Evaluation of retinal toxicity of acetylcholine in rabbit eyes. Retina (1995) 0.86
A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Vitrectomy for Macular Hole Study Group. Arch Ophthalmol (1999) 0.86
Modeling human eye aberrations and their compensation for high-resolution retinal imaging. Optom Vis Sci (1998) 0.86
Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate. Retina (1999) 0.86
Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol (2000) 0.86
Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis (1995) 0.85
Microtechniques for flow cytometric analysis of aqueous humor lymphocytes. J Immunol Methods (1984) 0.85
Evaluation of the human choroidal melanoma rabbit model for studying microcirculation patterns with confocal ICG and histology. Exp Eye Res (1999) 0.85